← Research library

Clinical efficacy of piracetam in cognitive impairment: a meta-analysis

Review of earlier studies · 2002

What was studied
19 double-blind placebo comparisons in older patients with cognitive impairment
Main finding
Reported a favorable pooled clinical global impression of change. This differs from the memory-specific outcome in the 2024 analysis.

Study data at a glance

Participants or experimental model
19 double-blind placebo comparisons in older patients with cognitive impairment
Reported results
Reported a favorable pooled clinical global impression of change. This differs from the memory-specific outcome in the 2024 analysis.
Study limitations and source details

Study limitations

  • Several authors were affiliated with UCB; the search included the manufacturer’s document database.
  • Older diagnostic definitions and outcome measures varied.
  • A review is not independent replication of its underlying trials.

Source details

University-hosted PDF: title page, abstract and study-selection methods checked; full risk-of-bias reassessment pending.

Sources checked

Citation

ReviewFull text available

T. Waegemans, C. R. Wilsher, A. Danniau, S. H. Ferris, A. Kurz, B. Winblad. Clinical efficacy of piracetam in cognitive impairment: a meta-analysis Dementia and Geriatric Cognitive Disorders 13:217–224

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards